This might be because FABP7 immunoreactivity was observed in only half to two-thirds of the GBM specimens as shown in our previous studies [7], and the number of libraries reported by UniGene may not be sufficient to "capture" all potentially positive tumors. The gene discussed is FABP7; the disease is glioblastoma.